威高血净筹划购买威高普瑞100%股权 10月20日起停牌

Core Viewpoint - Weigao Blood Purification (603014.SH) is planning to acquire 100% equity of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. through a share issuance [1] Group 1 - The company has applied for a trading suspension, which will take effect from October 20, 2025, and is expected to last no more than 10 trading days [1]